HOXA-AS3 and hepatocellular carcinoma: HOXA-AS3 is highly expressed in HCC cells and enhances PD-L1 expression by adsorbing miR-455-5p, thereby increasing the proliferation, migration, and invasion abilities of HCC cells, regulating the cell cycle, and inhibiting apoptosis (93).